greeksoup/ stock research
Stock research / United States / KNSA / Documents

Kiniksa Pharmaceuticals International, plc documents

Kiniksa Pharmaceuticals International (KNSA) annual report: the 10-K filed 24 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 16 April 2026; latest 10-Q filed 27 October 2026 for the quarter ended 30 September 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
27 October 2026Results press release, exhibit 99 to the 8-K filed 27 October 2026The releaseEDGAR folder
28 July 2026Results press release, exhibit 99 to the 8-K filed 28 July 2026The releaseEDGAR folder
28 April 2026Results press release, exhibit 99 to the 8-K filed 28 April 2026The releaseEDGAR folder
24 February 2026Results press release, exhibit 99 to the 8-K filed 24 February 2026The releaseEDGAR folder
12 January 2026Results press release, exhibit 99 to the 8-K filed 12 January 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
24 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
27 October 202610-Q, period ended 30 September 2026The documentEDGAR folder
28 July 202610-Q, period ended 30 June 2026The documentEDGAR folder
28 April 202610-Q, period ended 31 March 2026The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
16 April 2026DEF 14A, period ended 19 May 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
16 April 2026ARS, period ended 31 December 2025The documentEDGAR folder